In this study, PARP-1 inhibitor PJ34 was given to male and female MCAO mice at 48 h after MCAO, and our results demonstrated that delayed delivery of PJ34 could significantly block post-stroke microglial activation, alleviate neuro-inflammation in male and female MCAO mice(Figures 1–3). This evidence concerns the gene PARP1 and stroke disorder.